top of page

PENTAXIM VACCINE

Product details

Registration number: SIN14795P

Classification: Prescription Only

Active ingredients:

  • (Prefilled Syringe) Diphtheria toxoid
  • (Prefilled Syringe) Filamentous haemagglutinin
  • (Prefilled Syringe) Pertussis toxoid
  • (Prefilled Syringe) Poliovirus (inactivated) - Type 1 (Mahoney)
  • (Prefilled Syringe) Poliovirus (inactivated) - Type 2 (MEF-1)
  • (Prefilled Syringe) Poliovirus (inactivated) - Type 3 (Saukett)
  • (Prefilled Syringe) Tetanus toxoid
  • (Vial) Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to Tetanus protein
  • (Vial) Tetanus protein (PRP-T)

Strength:

  • min. 20 IU (30 Lf)/0.5 mL
  • 25 μg/0.5 mL
  • 25 μg/0.5 mL
  • 29 DU/0.5 mL
  • 7 DU/0.5 mL
  • 26 DU/0.5 mL
  • min. 40 IU (10 Lf) /0.5 mL
  • 10 μg/0.5 mL
  • 18 - 30 μg/0.5 mL

Dosage form: INJECTION, POWDER, FOR SUSPENSION

Route: INTRAMUSCULAR

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

ATC code: J07CA06

HSA approval date: 5 June 2015

Manufacturer(s):

  • Sanofi Winthrop Industrie, MLE
  • Sanofi Winthrop Industrie, VDR

Manufacturing country/countries: FRANCE

What are the HSA registration number and classification for PENTAXIM VACCINE?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14795P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for PENTAXIM VACCINE?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • (Prefilled Syringe) Diphtheria toxoid
  • (Prefilled Syringe) Filamentous haemagglutinin
  • (Prefilled Syringe) Pertussis toxoid
  • (Prefilled Syringe) Poliovirus (inactivated) - Type 1 (Mahoney)
  • (Prefilled Syringe) Poliovirus (inactivated) - Type 2 (MEF-1)
  • (Prefilled Syringe) Poliovirus (inactivated) - Type 3 (Saukett)
  • (Prefilled Syringe) Tetanus toxoid
  • (Vial) Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to Tetanus protein
  • (Vial) Tetanus protein (PRP-T)

Strength:

  • min. 20 IU (30 Lf)/0.5 mL
  • 25 μg/0.5 mL
  • 25 μg/0.5 mL
  • 29 DU/0.5 mL
  • 7 DU/0.5 mL
  • 26 DU/0.5 mL
  • min. 40 IU (10 Lf) /0.5 mL
  • 10 μg/0.5 mL
  • 18 - 30 μg/0.5 mL

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for PENTAXIM VACCINE?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SUSPENSION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for PENTAXIM VACCINE?

According to the HSA dataset updated 7 August 2026:

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for PENTAXIM VACCINE?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Sanofi Winthrop Industrie, MLE
  • Sanofi Winthrop Industrie, VDR

Manufacturing country/countries: FRANCE

Source for this answer

Where can I look up PENTAXIM VACCINE in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14795P or the exact product name PENTAXIM VACCINE. The general register link does not preselect this product.

Source for this answer

What are the source dates for this PENTAXIM VACCINE record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this PENTAXIM VACCINE record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14795P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page